Top Markets
Coin of the day
Hunan Er-Kang Pharmaceutical Co., Ltd Hunan Er-Kang Pharmaceutical Co., Ltd

Hunan Er-Kang Pharmaceutical Co., Ltd

300267
Rangering i aksjer #9472
Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that... Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.
Aksjekurs
$0.48835979
Sist synkronisert: 2026-08-28
Markedsverdi
$1.01B
Endring (1 dag)
-1.46%
Endring (1 år)
-9.78%
Land
CN
Handel Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

Kategori

EPS for Hunan Er-Kang Pharmaceutical Co., Ltd (300267)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Hunan Er-Kang Pharmaceutical Co., Ltd er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Hunan Er-Kang Pharmaceutical Co., Ltd fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter